---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-007224"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:15:06.020873+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Profound Medical signs exclusive distribution deal for TULSA-PRO in Australia, New Zealand

## Summary
- Exclusive distribution & supply agreement with Getz Healthcare for TULSA-PRO system in Australia and New Zealand.
- TULSA-PRO is an AI-powered, MRI-guided robotic system for real-time prostate ablation without surgery or radiation.
- Partnership leverages Getz Healthcare's established distribution network in the region.
- Profound also deploys direct sales in North America while partnering with strategic distributors internationally.

## SEC filing metadata
- accession: 0001171843-25-007224
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184325007224/0001171843-25-007224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184325007224/f8k_111225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-007224
- JSON: https://secwatch.observer/filing/0001171843-25-007224.json
- Plain text: https://secwatch.observer/filing/0001171843-25-007224.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.